Skip to main content
  • Sign in
    Welcome !
    My account
    Logout
  1. Life Sciences
  2. Biological Products, (No Diagnostic Substances)
  3. Lineage Cell Therapeutics, Inc.

Lineage Cell Therapeutics, Inc. (LCTX) Stock Forecast

Stock Price Forecast

Aug. 15, 2025

Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict

Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Lineage Cell Therapeutics, Inc. chart...

About the Company

Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its robust proprietary cell-based therapy platform and associated in-house development and manufacturing capabilities. With this platform Lineage develops and manufactures specialized, terminally differentiated human cells from its pluripotent and progenitor cell starting materials. These differentiated cells are developed to either replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury or administered as a means of helping the body mount an effective immune response to cancer. Lineage’s clinical and preclinical programs are in markets with billion dollar opportunities and include five allogeneic (“off-the-shelf”) product candidates: (i) OpRegen®, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, which is being developed under a worldwide collaboration with Genentech, a member of the Roche Group; (ii) OPC1, an oligodendrocyte progenitor cell therapy in Phase 1/2a development for the treatment of acute spinal cord injuries; (iii) VAC2, an allogeneic dendritic cell therapy produced from Lineage's VAC technology platform for immuno-oncology and infectious disease, currently in Phase 1 clinical development for the treatment of non-small cell lung cancer; (iv) ANP1, an auditory neuronal progenitor cell therapy for the potential treatment of auditory neuropathy; and (v) PNC1, a photoreceptor neural cell therapy for the potential treatment of vision loss due to photoreceptor dysfunction or damage.

Sector

Life Sciences

Industry

Biological Products, (No Diagnostic Substances)

Employees

46

Exchange

NYSE

$10M

Total Revenue

46

Employees

$267M

Market Capitalization

-4.73

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest News on Lineage Cell Therapeutics, Inc.

Lineage Cell Therapeutics, Inc. (AMEX:LCTX) Q2 2025 Earnings Call Transcript

on MSN ago, source: Insider Monkey on MSN.com

Q2 2025 Earnings Call Transcript August 12, 2025 Lineage Cell Therapeutics, Inc. misses on earnings expectations. Reported ...

Lineage Cell Therapeutics Inc (LCTX) Q2 2025 Earnings Call Highlights: Strategic Partnerships ...

9d ago, source: Yahoo Finance

Lineage Cell Therapeutics Inc (LCTX) showcases promising clinical trial results and strategic collaborations, while ...

Lineage Cell Therapeutics Reports Q2 2025 Progress and Challenges

9d ago, source: None

Lineage Cell Therapeutics, Inc. ( ($LCTX) ) has released its Q2 earnings. Here is a breakdown of the information Lineage Cell Therapeutics, Inc.

Lineage Cell Therapeutics Announces Pricing of up to $66 Million ...

9mon ago, source: Business Wire

About Lineage Cell Therapeutics, Inc. Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel, “off-the-shelf,” cell therapies to address unmet medical needs.

Lineage Cell Therapeutics Inc LCTX - Morningstar

2mon ago, source: Morningstar

Review the current Lineage Cell Therapeutics Inc (LCTX:XASE) growth, profitability and efficiency, financial health, and cash flow key metrics to decide if LCTX is the best investment for you.

Lineage Cell Therapeutics Reports Third Quarter 2024 Financial ... - Nasdaq

9mon ago, source: Nasdaq

Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today reported its third quarter 2024 financial and operating ...

Lineage Cell Therapeutics Announces Closing of Second Tranche of ...

6mon ago, source: Business Wire

About Lineage Cell Therapeutics, Inc. Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel, “off-the-shelf,” cell therapies to address unmet medical needs.

Lineage Cell Therapeutics to Report Fourth Quarter and Full ... - Nasdaq

5mon ago, source: Nasdaq

Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company developing allogeneic cell therapies for serious neurological conditions, today announced that it will report its fourth ...

Lineage Cell Therapeutics, Inc. (LCTX) Q1 2025 Earnings Call Transcript

3mon ago, source: Seeking Alpha

Lineage Cell Therapeutics, Inc. (NYSE:LCTX) Q1 2025 - Earnings Conference Call May 13, 2025 4:30 PM ETCompany ParticipantsIoana Hone - Head of Investor ...

Lineage Cell Therapeutics, Inc. (LCTX) Q1 2024 Earnings Call Transcript

1y ago, source: Seeking Alpha

Lineage Cell Therapeutics, Inc. (NYSE:LCTX) Q1 2024 Earnings Conference Call May 9, 2024 4:30 PM ET Company Participants Ioana Hone - Head, Investor Relations Brian Culley - Chief Executive Officer ...

Lineage Cell Therapeutics Announces First Closing of up to $66 Million ...

9mon ago, source: Eagle-Tribune

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced the first ...

Similar Companies
Company Ticker 90 Days Forecast Market Cap. (USD M) P/E P/B
Acumen Pharmaceuticals, Inc. ABOS Predict 86.01 -1.85 0.73
Abpro Holdings, Inc. ABP Predict 0.00 None 0.00
Abpro Holdings, Inc. ABPWW Predict 0.00 None 0.00
Arcellx, Inc. ACLX Predict 3724.66 -74.09 8.93
Alpha Cognition Inc. ACOG Predict 136.20 None 4.27
Adaptimmune Therapeutics PLC ADAP Predict 95.42 -13.20 -11.77
ADMA BIOLOGICS, INC. ADMA Predict 4202.33 20.11 10.55
Adaptive Biotechnologies Corp ADPT Predict 2009.00 -4.61 11.18
Adverum Biotechnologies, Inc. ADVM Predict 57.66 -1.75 2.18
AGENUS INC AGEN Predict 138.92 -0.47 -0.49
AIM ImmunoTech Inc. AIM Predict 2.03 -0.48 -183.28
AIM ImmunoTech Inc. AIMI Predict 2.03 None None
Alector, Inc. ALEC Predict 217.10 -1.19 3.05
Aligos Therapeutics, Inc. ALGS Predict 72.39 -19.24 0.71
Allogene Therapeutics, Inc. ALLO Predict 241.05 -1.39 0.70
Kalaris Therapeutics, Inc. ALVR Predict 49.48 -0.48 0.44
AMGEN INC AMGN Predict 160006.17 24.17 21.54
Apogee Therapeutics, Inc. APGE Predict 2221.79 -20.51 4.25
Aptose Biosciences Inc. APTO Predict 5.90 -0.04 -1.30
Aptose Biosciences Inc. APTOF Predict 3.17 None None
Armata Pharmaceuticals, Inc. ARMP Predict 92.29 -0.99 -1.62
Artiva Biotherapeutics, Inc. ARTV Predict 66.99 None 0.45
Athira Pharma, Inc. ATHA Predict 15.82 -0.21 0.49
Atara Biotherapeutics, Inc. ATRA Predict 142.27 24.55 -1.08
aTYR PHARMA INC ATYR Predict 515.34 -3.56 6.87
Aura Biosciences, Inc. AURA Predict 417.12 -4.92 2.39
Autolus Therapeutics plc AUTL Predict 481.70 None 1.39
ANAVEX LIFE SCIENCES CORP. AVXL Predict 815.68 -17.34 8.97
BioAtla, Inc. BCAB Predict 124.77 -1.05 1.00
BioCardia, Inc. BCDA Predict 11.81 -0.59 -7.77
BRAINSTORM CELL THERAPEUTICS INC. BCLI Predict 6.38 -4.86 -0.89
BIOCRYST PHARMACEUTICALS INC BCRX Predict 1801.64 -12.05 -3.99
Black Diamond Therapeutics, Inc. BDTX Predict 158.63 10.99 1.20
Beam Therapeutics Inc. BEAM Predict 1688.72 -12.55 1.61
BIOGEN INC. BIIB Predict 18125.49 12.80 1.54
Black Hawk Acquisition Corp BKHA Predict 0.00 None 0.00
Black Hawk Acquisition Corp BKHAU Predict 0.00 None 0.00
bluebird bio, Inc. BLUE Predict 48.67 -0.17 -0.84
Cabaletta Bio, Inc. CABA Predict 156.38 -1.57 0.88
Candel Therapeutics, Inc. CADL Predict 337.69 -4.60 4.52
C4 Therapeutics, Inc. CCCC Predict 206.62 -2.63 1.19
Cidara Therapeutics, Inc. CDTX Predict 728.26 -0.96 5.14
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. CELZ Predict 8.05 -3.38 1.18
CERO THERAPEUTICS HOLDINGS, INC. CERO Predict 27.42 None -196.22
CERO THERAPEUTICS HOLDINGS, INC. CEROW Predict 1.74 None -0.47
Cullinan Therapeutics, Inc. CGEM Predict 449.26 -4.05 0.81
COMPUGEN LTD CGEN Predict 133.76 None 2.66
CG Oncology, Inc. CGON Predict 2059.02 None 3.07
COGNITION THERAPEUTICS INC CGTX Predict 100.04 -0.47 14.23
Pelthos Therapeutics Inc. CHRO Predict 8.35 None -1.99
Coherus Oncology, Inc. CHRS Predict 122.03 0.68 1.02
Calidi Biotherapeutics, Inc. CLDI Predict 17.94 -0.92 10.17
Compass Therapeutics, Inc. CMPX Predict 410.70 -4.81 4.41
Coeptis Therapeutics Holdings, Inc. COEPW Predict None None None
Caribou Biosciences, Inc. CRBU Predict 184.38 -1.51 1.11
Cardiff Oncology, Inc. CRDF Predict 162.32 -4.00 2.77
CARGO Therapeutics, Inc. CRGX Predict 214.53 None 0.90
CURIS INC CRIS Predict 18.53 -0.30 -2.85
CRISPR Therapeutics AG CRSP Predict 4668.04 -12.09 2.73
CHAMPIONS ONCOLOGY, INC. CSBR Predict 111.31 -17.77 20.35
CEL SCI CORP CVM Predict 46.99 -0.93 6.69
Cyclo Therapeutics, Inc. CYTH Predict 26.18 -0.57 -1.94
Cyclo Therapeutics, Inc. CYTHW Predict 6.65 None -0.49
DBV Technologies S.A. DBVT Predict 1479.05 -3.33 514.81
Ginkgo Bioworks Holdings, Inc. DNA Predict 567.98 -13.93 0.33
Denali Therapeutics Inc. DNLI Predict 2110.86 -8.66 1.88
PRECISION BIOSCIENCES INC DTIL Predict 54.81 -2.17 1.61
DYADIC INTERNATIONAL INC DYAI Predict 28.05 -7.31 11.35
Editas Medicine, Inc. EDIT Predict 231.05 -0.80 3.70
Elevation Oncology, Inc. ELEV Predict 22.21 -0.96 0.48
ELUTIA INC. ELUT Predict 90.43 -1.42 -0.06
enGene Holdings Inc. ENGN Predict 187.94 3.71 0.83
enGene Holdings Inc. ENGNW Predict 37.21 None 0.14
Entera Bio Ltd. ENTX Predict 90.90 8.51 5.27
ENZO BIOCHEM INC ENZ Predict 25.15 -2.98 0.54
ENZO BIOCHEM INC ENZB Predict 36.16 None 0.83
Estrella Immunopharma, Inc. ESLA Predict 34.08 -3.06 -16.85
Estrella Immunopharma, Inc. ESLAW Predict 3.98 None 5.33
EXELIXIS, INC. EXEL Predict 11082.09 18.40 5.45
EXOZYMES INC. EXOZ Predict 81.79 None 11.30
FATE THERAPEUTICS INC FATE Predict 129.11 -1.29 0.49
4D Molecular Therapeutics, Inc. FDMT Predict 405.37 -2.98 0.96
FENNEC PHARMACEUTICALS INC. FENC Predict 231.85 1758.27 -39.67
Finch Therapeutics Group, Inc. FNCH Predict 20.39 -0.05 1.43
FutureTech II Acquisition Corp. FTII Predict -26.18 None -0.72
FutureTech II Acquisition Corp. FTIIU Predict -25.54 None -0.78
FutureTech II Acquisition Corp. FTIIW Predict 0.01 None 0.00
GILEAD SCIENCES, INC. GILD Predict 145987.98 23.13 7.42
Monte Rosa Therapeutics, Inc. GLUE Predict 379.64 15.71 1.42
Genenta Science S.p.A. GNTA Predict 64.11 None 5.13
Green Planet Bio Engineering Co. Ltd. GPLB Predict None None None
HALOZYME THERAPEUTICS, INC. HALO Predict 8983.62 16.12 27.00
HilleVax, Inc. HLVX Predict 104.26 -0.60 0.70
Humacyte, Inc. HUMA Predict 293.92 -3.31 72.54
Humacyte, Inc. HUMAW Predict 162.99 None -2.56
ImmunityBio, Inc. IBRX Predict 2427.21 -3.63 -4.10
Ikena Oncology, Inc. IKNA Predict 61.29 -1.27 0.52
Inhibikase Therapeutics, Inc. IKT Predict 157.11 -0.95 1.96
Immunocore Holdings plc IMCR Predict 1655.23 None 4.26
Immunovant, Inc. IMVT Predict 2612.23 -14.45 4.29
IN8BIO, INC. INAB Predict 20.73 -0.40 2.41
Inhibrx Biosciences, Inc. INBX Predict 360.87 -6.76 5.26
MiNK Therapeutics, Inc. INKT Predict 59.25 -1.46 -1.36
Inmune Bio, Inc. INMB Predict 67.26 -2.49 2.33
INTENSITY THERAPEUTICS, INC. INTS Predict 7.72 -2.18 3.53
IOVANCE BIOTHERAPEUTICS, INC. IOVA Predict 865.06 -4.50 1.24
Century Therapeutics, Inc. IPSC Predict 48.51 -0.69 0.23
iTeos Therapeutics, Inc. ITOS Predict 392.69 -2.76 0.70
Invivyd, Inc. IVVD Predict 84.94 -0.35 1.99
EXOZYMES INC. IZTC Predict 99.04 None -27.50
Jasper Therapeutics, Inc. JSPR Predict 50.44 -3.21 2.15
Jasper Therapeutics, Inc. JSPRW Predict 3.30 None 0.04
Kalaris Therapeutics, Inc. KLRS Predict 46.01 None 0.87
Klotho Neurosciences, Inc. KLTO Predict 24.52 None 38.39
Klotho Neurosciences, Inc. KLTOW Predict 0.59 None 0.41
Kodiak Sciences Inc. KOD Predict 558.59 -2.45 7.95
Kiromic Biopharma, Inc. KRBPQ Predict 0.01 None None
Krystal Biotech, Inc. KRYS Predict 4344.63 29.61 4.17
Kymera Therapeutics, Inc. KYMR Predict 3550.82 -17.77 3.65
Kyverna Therapeutics, Inc. KYTX Predict 153.09 None 0.83
LadRx Corp LADX Predict None None None
Lineage Cell Therapeutics, Inc. LCTX Predict 266.82 -4.73 5.51
LENZ Therapeutics, Inc. LENZ Predict 1138.86 -6.72 5.52
Liminatus Pharma, Inc. LIMN Predict 0.00 None None
Lexeo Therapeutics, Inc. LXEO Predict 254.87 -0.35 1.84
Maze Therapeutics, Inc. MAZE Predict 590.23 None 2.25
MeiraGTx Holdings plc MGTX Predict 692.75 -3.40 20.93
Metagenomi, Inc. MGX Predict 69.81 None 0.36
Moderna, Inc. MRNA Predict 10199.58 -3.15 1.08
NEUROCRINE BIOSCIENCES INC NBIX Predict 13771.50 39.54 5.11
NKGen Biotech, Inc. NKGN Predict 3.61 -0.10 -0.19
NKGen Biotech, Inc. NKGNW Predict 0.78 None -0.01
Neumora Therapeutics, Inc. NMRA Predict 263.36 -3.90 1.44
NOVAVAX INC NVAX Predict 1389.42 3.29 36.93
Ocugen, Inc. OCGN Predict 297.87 -4.29 18.72
Omega Therapeutics, Inc. OMGA Predict 8.86 -0.68 0.77
Omega Therapeutics, Inc. OMGAQ Predict 0.17 None 0.01
VivoSim Labs, INC. ONVO Predict 34.91 -0.36 95.90
Outlook Therapeutics, Inc. OTLK Predict 73.18 -0.17 -2.25
PALISADE BIO, INC. PALI Predict 3.60 -0.15 0.67
Passage BIO, Inc. PASG Predict 22.95 -0.57 0.60
Vaxcyte, Inc. PCVX Predict 4335.40 -20.36 1.41
BiomX Inc. PHGE Predict 15.21 1.47 0.79
Pluri Inc. PLUR Predict -3.99 -1.36 -9.10
Protalix BioTherapeutics, Inc. PLX Predict 114.92 18.32 2.30
PharmaCyte Biotech, Inc. PMCB Predict 7.32 -2.55 0.18
Prime Medicine, Inc. PRME Predict 480.15 -1.51 7.89
PROKIDNEY CORP. PROK Predict -68.32 None 0.00
Poseida Therapeutics, Inc. PSTX Predict 925.92 -9.59 10.62
Pelthos Therapeutics Inc. PTHS Predict None None None
QIAGEN N.V. QGEN Predict 11040.35 None 3.10
Quince Therapeutics, Inc. QNCX Predict 89.55 -1.66 7.63
Replimune Group, Inc. REPL Predict 931.98 -3.76 2.24
REPLIGEN CORP RGEN Predict 6531.29 8219.12 3.29
REGENXBIO Inc. RGNX Predict 453.55 -1.81 2.12
Relay Therapeutics, Inc. RLAY Predict 607.79 -1.97 0.91
Revolution Medicines, Inc. RVMD Predict 7134.05 -11.09 3.43
Revolution Medicines, Inc. RVMDW Predict 15.98 None 0.01
RECURSION PHARMACEUTICALS, INC. RXRX Predict 2203.11 -4.69 2.40
SAB Biotherapeutics, Inc. SABS Predict 23.99 -2.28 1.12
SAB Biotherapeutics, Inc. SABSW Predict 0.34 None 0.01
Sana Biotechnology, Inc. SANA Predict 852.24 -2.06 6.95
Scilex Holding Co SCLX Predict 61.59 -0.41 -0.29
Scilex Holding Co SCLXW Predict 24.51 None -0.12
Scinai Immunotherapeutics Ltd. SCNI Predict 5325.60 -287.75 -2577.24
SANGAMO THERAPEUTICS, INC SGMO Predict 138.45 -1.56 7.06
Solid Biosciences Inc. SLDB Predict 495.32 -0.85 1.68
Silexion Therapeutics Corp SLXN Predict 4.20 None 34.97
Silexion Therapeutics Corp SLXNW Predict 865.67 None -189.05
Senti Biosciences, Inc. SNTI Predict 50.86 -1.07 1.34
Scholar Rock Holding Corp SRRK Predict 4069.37 -18.48 13.03
Surrozen, Inc./DE SRZN Predict 95.47 -0.49 2.03
Surrozen, Inc./DE SRZNW Predict 0.09 None 0.02
SUTRO BIOPHARMA, INC. STRO Predict 77.50 -1.04 -2.52
SpringWorks Therapeutics, Inc. SWTX Predict 3539.41 -9.90 8.48
Protara Therapeutics, Inc. TARA Predict 125.73 -2.07 0.87
Tarsus Pharmaceuticals, Inc. TARS Predict 2408.98 -12.37 7.24
TC BioPharm (Holdings) plc TCBP Predict 37.26 None 34.48
TC BioPharm (Holdings) plc TCBPW Predict 1.03 None 0.95
TC BioPharm (Holdings) plc TCBPY Predict 17.57 None 16.26
TScan Therapeutics, Inc. TCRX Predict 233.47 -4.63 1.32
BIO-TECHNE Corp TECH Predict 8155.03 75.16 4.04
Tectonic Therapeutic, Inc. TECX Predict 439.92 -8.86 1.55
Instil Bio, Inc. TIL Predict 181.71 -1.13 1.25
Tenaya Therapeutics, Inc. TNYA Predict 158.31 -2.45 1.59
Tourmaline Bio, Inc. TRML Predict 580.57 -3.46 2.24
Turnstone Biologics Corp. TSBX Predict 8.21 -0.14 0.56
Taysha Gene Therapies, Inc. TSHA Predict 805.78 -3.01 3.24
TITAN PHARMACEUTICALS INC TTNP Predict 8.35 -0.46 4.45
Tevogen Bio Holdings Inc. TVGN Predict 183.62 None -29.30
Tevogen Bio Holdings Inc. TVGNW Predict 11.47 None -1.85
Twist Bioscience Corp TWST Predict 1711.95 -12.57 3.58
Voyager Acquisition Corp./Cayman Islands VACH Predict -1435.46 None 0.00
Voyager Acquisition Corp./Cayman Islands VACHU Predict -1584.56 None 0.00
Vericel Corp VCEL Predict 1863.29 262.18 6.07
Vigil Neuroscience, Inc. VIGL Predict 383.88 -1.06 9.30
Vir Biotechnology, Inc. VIR Predict 627.77 -2.04 0.66
VivoSim Labs, INC. VIVS Predict 3.32 None 0.32
Vor Biopharma Inc. VOR Predict 268.88 -0.56 3.91
Vaxart, Inc. VXRT Predict 84.70 -0.85 2.58
Voyager Therapeutics, Inc. VYGR Predict 218.24 570.60 0.90
WINDTREE THERAPEUTICS INC /DE/ WINT Predict 18.34 -0.44 4.16
X4 Pharmaceuticals, Inc XFOR Predict 8.28 6.44 0.36
Zivo Bioscience, Inc. ZIVO Predict 69.66 -31.25 -1.99
Zura Bio Ltd ZURA Predict 130.60 5.01 0.94

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Investment Dashboard

Loading your portfolio...